NCT06494397View on ClinicalTrials.gov

Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

July 11, 2024

Primary Completion Date

October 24, 2024

Study Completion Date

October 24, 2024

Conditions
SchizophreniaBipolar I Disorder
Interventions
DRUG

VHX-896 and iloperidone

oral tablet

DRUG

Iloperidone and VHX-896

oral tablet

Trial Locations (3)

20877

Vanda Investigational Site, Gaithersburg

90720

Vanda Investigational Site, Los Alamitos

08053

Vanda Investigational Site, Marlton

Sponsors
All Listed Sponsors
lead

Vanda Pharmaceuticals

INDUSTRY

NCT06494397 - Pharmacokinetic Study of VHX-896 and Iloperidone Tablets Under Steady-State Conditions | Biotech Hunter | Biotech Hunter